STOCK TITAN

CRM insider Benioff trades 2,250 shares under 10b5-1 plan

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Salesforce (CRM) Chair and CEO Marc Benioff reported an option exercise and related sales on 10/15/2025 under a pre‑set Rule 10b5‑1 trading plan adopted on January 9, 2025. He exercised 2,250 non-qualified stock options at an exercise price of $161.50 per share and sold 2,250 common shares in five tranches at weighted average prices of $236.6085, $237.7581, $238.4893, $239.6334, and $240.5481.

Following these transactions, Benioff directly beneficially owned 11,911,571 common shares. He also reported 107,000 shares held indirectly by a trust and 10,000,000 shares held indirectly by Marc Benioff Fund LLC. After the exercise, he held 27,122 derivative securities (non-qualified stock options). The option referenced vested beginning March 22, 2020, with monthly installments thereafter through March 22, 2023.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 4: option exercise and matched sales under 10b5-1.

The filing shows Marc Benioff exercised $161.50 non-qualified options for 2,250 shares and sold the same number of shares on 10/15/2025. The sales were executed pursuant to a Rule 10b5-1 plan adopted on January 9, 2025, indicating pre-arranged parameters.

Post-transaction, direct beneficial ownership is 11,911,571 shares, with additional indirect holdings of 107,000 shares by trust and 10,000,000 by Marc Benioff Fund LLC. The derivative line shows 27,122 remaining options. These are administrative disclosures; actual market impact depends on holder actions and broader trading volume.

Insider Benioff Marc
Role Chair and CEO
Sold 2,250 shs ($536K)
Type Security Shares Price Value
Exercise Non-qualified Stock Option (Right to Buy) 2,250 $0.00 --
Exercise Common Stock 2,250 $161.50 $363K
Sale Common Stock 629 $236.6085 $149K
Sale Common Stock 611 $237.7581 $145K
Sale Common Stock 175 $238.4893 $42K
Sale Common Stock 403 $239.6334 $97K
Sale Common Stock 432 $240.5481 $104K
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Non-qualified Stock Option (Right to Buy) — 27,122 shares (Direct); Common Stock — 11,913,821 shares (Direct); Common Stock — 107,000 shares (Indirect, By Trust)
Footnotes (1)
  1. As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025. Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. Weighted average price. These shares were sold in multiple transactions at prices ranging from $236.1600 to $237.1500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $237.1600 to $238.1500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $238.1600 to $238.9555 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $239.1671 to $240.1600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $240.1700 to $240.8900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Shares held in the Marc Benioff Fund LLC (the "Fund"). Fund interests are held in the reporting person's name or in trust. Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Benioff Marc

(Last) (First) (Middle)
415 MISSION STREET
3RD FLOOR

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Salesforce, Inc. [ CRM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chair and CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/15/2025 M(1) 2,250 A $161.5 11,913,821 D(2)
Common Stock 10/15/2025 S(1) 629 D $236.6085(3) 11,913,192 D(2)
Common Stock 10/15/2025 S(1) 611 D $237.7581(4) 11,912,581 D(2)
Common Stock 10/15/2025 S(1) 175 D $238.4893(5) 11,912,406 D(2)
Common Stock 10/15/2025 S(1) 403 D $239.6334(6) 11,912,003 D(2)
Common Stock 10/15/2025 S(1) 432 D $240.5481(7) 11,911,571 D(2)
Common Stock 107,000 I By Trust
Common Stock 10,000,000 I(8) By Marc Benioff Fund LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified Stock Option (Right to Buy) $161.5 10/15/2025 M(1) 2,250 03/22/2020(9) 03/22/2026 Common Stock 2,250 $0 27,122 D
Explanation of Responses:
1. As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.
2. Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.
3. Weighted average price. These shares were sold in multiple transactions at prices ranging from $236.1600 to $237.1500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
4. Weighted average price. These shares were sold in multiple transactions at prices ranging from $237.1600 to $238.1500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
5. Weighted average price. These shares were sold in multiple transactions at prices ranging from $238.1600 to $238.9555 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
6. Weighted average price. These shares were sold in multiple transactions at prices ranging from $239.1671 to $240.1600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
7. Weighted average price. These shares were sold in multiple transactions at prices ranging from $240.1700 to $240.8900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
8. Shares held in the Marc Benioff Fund LLC (the "Fund"). Fund interests are held in the reporting person's name or in trust.
9. Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff 10/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Salesforce (CRM) CEO Marc Benioff report on Form 4?

He exercised 2,250 options at $161.50 and sold 2,250 shares on 10/15/2025 under a Rule 10b5-1 plan.

At what prices were the CRM shares sold by Marc Benioff?

Five weighted-average prices: $236.6085, $237.7581, $238.4893, $239.6334, and $240.5481.

How many Salesforce shares does Marc Benioff own after the transactions?

Directly 11,911,571 shares; indirectly 107,000 by a trust and 10,000,000 by Marc Benioff Fund LLC.

What derivative holdings remain after the option exercise?

He reported 27,122 non-qualified stock options beneficially owned following the transactions.

Was the transaction executed under a Rule 10b5-1 plan?

Yes. The filing states it was effected automatically under a Rule 10b5-1 plan adopted on January 9, 2025.

What are the vesting terms for the exercised option?

It vested 25% on March 22, 2020, with the balance vesting in equal monthly installments over the next 36 months.